Published in:
01-12-2020 | Non-Invasive Ventilation | Letter
High-flow nasal cannula can’t be considered non-inferior to noninvasive ventilation in patients with chronic obstructive pulmonary disease who develop respiratory failure after extubation
Authors:
Robert V. Curtis, Badih A. Kabchi, Shehabaldin Alqalyoobi
Published in:
Critical Care
|
Issue 1/2020
Login to get access
Excerpt
We read the article published recently in Critical Care by Tan et al. with great interest. We appreciate their effort to evaluate high flow nasal cannula (HFNC) usage in post-extubated chronic obstructive pulmonary disease (COPD) patients with respiratory failure [
1]. A non-inferiority study is a reasonable approach given NIV has shown benefit in post-extubation studies [
2‐
4]. Unlike superiority trials, non-inferiority studies establish non-inferiority by rejecting a null hypothesis that the tested treatment is worse than the comparator by a pre-established minimum difference (non-inferiority cutoff or delta) based on results from prior studies [
5]. However, several issues in this study prevent us from reaching this conclusion. …